716378915	716378915	CD	B-NP	O
|	|	NN	I-NP	O
IOSH	IOSH	NN	I-NP	O
|	|	NN	I-NP	O
71574012	71574012	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2855548	2855548	CD	B-NP	O
|	|	CC	I-NP	O
8/27/2004	8/27/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
HO	HO	NN	I-NP	I-protein
evaluation	evaluation	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/27/2004	8/27/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/4/2004	9/4/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
GIOTTONINI	GIOTTONINI	NN	B-NP	O
,	,	,	O	O
MARC	MARC	NN	B-NP	O
490-30-61-5	490-30-61-5	CD	I-NP	O
Peakesonwin	Peakesonwin	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
8/12/04	8/12/04	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
WILMOT	WILMOT	NNP	B-NP	O
,	,	,	O	O
MARIANO	MARIANO	NNP	B-NP	O
CLINTON	CLINTON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
PHOSLO	PHOSLO	NN	B-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
CALCIUM	CALCIUM	NNP	I-NP	I-protein
ACETATE	ACETATE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
667	667	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	I-protein
PREMARIN	PREMARIN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
CONJUGATED	CONJUGATED	NNP	I-NP	I-protein
ESTROGENS	ESTROGENS	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
CREAM	CREAM	NN	I-NP	I-protein
TP	TP	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
COLACE	COLACE	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
HUMULIN	HUMULIN	NNP	I-NP	I-protein
N	N	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
55	55	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
;	;	:	O	O
25	25	CD	B-NP	O
UNITS	UNITS	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
SC	SC	NNP	I-NP	O
55	55	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
25	25	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
METHAZOLAMIDE	METHAZOLAMIDE	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
7	7	CD	B-NP	O
METHOCARBAMOL	METHOCARBAMOL	NN	I-NP	O
500	500	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
TIMOLOL	TIMOLOL	NNP	I-NP	O
MALEATE	MALEATE	NNP	I-NP	O
0.5	0.5	CD	B-NP	O
%	%	NN	I-NP	O
1	1	CD	B-NP	O
DROP	DROP	NN	I-NP	O
OS	OS	NN	I-NP	O
BID	BID	NN	I-NP	O
VANCOMYCIN	VANCOMYCIN	NN	I-NP	O
HCL	HCL	NN	I-NP	O
1	1	CD	I-NP	O
GM	GM	NNP	I-NP	O
IV	IV	CD	I-NP	O
Q24H	Q24H	NN	I-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
May	May	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/12/04	2/12/04	CD	B-NP	O
by	by	IN	B-PP	O
CAMERINO	CAMERINO	NNP	B-NP	O
,	,	,	O	O
DENNIS	DENNIS	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
BACTRIM	BACTRIM	NN	B-NP	O
DS	DS	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
66844544	66844544	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SULFAMETHOXAZOLE	SULFAMETHOXAZOLE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/12/04	2/12/04	CD	B-NP	O
by	by	IN	B-PP	O
RAAD	RAAD	NN	B-NP	B-protein
,	,	,	O	O
TOM	TOM	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ZOCOR	ZOCOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
12353846	12353846	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ZOCOR	ZOCOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/12/04	2/12/04	CD	B-NP	O
by	by	IN	B-PP	O
HERNANDER	HERNANDER	NN	B-NP	O
,	,	,	O	O
CLAUDE	CLAUDE	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
NORVASC	NORVASC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

TOPROL	TOPROL	NN	B-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SUST	SUST	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O

25	25	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
IMDUR	IMDUR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ISOSORBIDE	ISOSORBIDE	NN	I-NP	O
MONONIT	MONONIT	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	O
SR	SR	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
60	60	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ALPHAGAN	ALPHAGAN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BRIMONIDINE	BRIMONIDINE	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
DROP	DROP	NNP	I-NP	O
OS	OS	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
MICONAZOLE	MICONAZOLE	NN	I-NP	O
NITRATE	NITRATE	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
POWDER	POWDER	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
apply	apply	RB	B-ADVP	O
to	to	TO	B-PP	O
buttocks	buttock	NNS	B-NP	O
and	and	CC	O	O
breast	breast	NN	B-NP	O
folds	fold	NNS	I-NP	O
.	.	.	O	O

ZANTAC	ZANTAC	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
RANITIDINE	RANITIDINE	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
150	150	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
LISINOPRIL	LISINOPRIL	NNP	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
BUMETANIDE	BUMETANIDE	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
February	February	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-VP	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Casebolt	Casebolt	NNP	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
8/29/04	8/29/04	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
28	28	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Eliseo	Eliseo	NNP	I-NP	O
Osentowski	Osentowski	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
UTI	UTI	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
DM	DM	NNP	I-NP	O
,	,	,	O	O
hx	hx	NN	B-NP	O
DKA	DKA	NN	I-NP	O
obesity	obesity	NN	I-NP	O
arthritis	arthritis	NN	I-NP	O
HTN	HTN	NN	I-NP	O
urate	urate	NN	I-NP	O
nephrolithiasis	nephrolithiasis	NN	I-NP	O
dvt	dvt	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
related	related	JJ	I-NP	O
hypoventilation	hypoventilation	NN	I-NP	O
DJD	DJD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
OA	OA	NN	I-NP	O
of	of	IN	B-PP	O
knees	knee	NNS	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
elevated	elevated	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
depression	depression	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
depression	depression	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
IDDM	IDDM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
dysuria	dysuria	NN	B-NP	O
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
week	week	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
62	62	CD	B-NP	O
y/o	y/o	NN	I-NP	O
woman	woman	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
a	a	DT	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
EF45	EF45	NN	I-NP	B-protein
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
presents	present	VBZ	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
week	week	NN	I-NP	O
of	of	IN	B-PP	O
dysuria	dysuria	NN	B-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
weeks	week	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
dx	dx	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
UTI	UTI	NN	I-NP	O
and	and	CC	O	O
treated	treat	VBN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
but	but	CC	O	O
continue	continue	VBP	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
dysuria	dysuria	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
grew	grow	VBD	B-VP	O
in	in	IN	B-PP	O
intensity	intensity	NN	B-NP	O
until	until	IN	B-SBAR	O
it	it	PRP	B-NP	O
elicited	elicit	VBD	B-VP	O
terror	terror	NN	B-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
some	some	DT	B-NP	O
constipation	constipation	NN	I-NP	O
+	+	SYM	B-NP	O
abd	abd	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
urine	urine	NN	I-NP	O
cx	cx	NN	I-NP	O
grew	grow	VBD	B-VP	O
as	as	IN	B-PP	O
MRSA	MRSA	NN	B-NP	B-protein
.	.	.	O	O

Given	Give	VBN	B-VP	O
bactrim	bactrim	JJ	B-ADJP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
;	;	:	O	O
found	find	VBN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
elevated	elevated	JJ	B-NP	O
BUN/Cr	BUN/Cr	NN	I-NP	O
and	and	CC	O	O
slight	slight	JJ	B-NP	O
hyperkalemia	hyperkalemia	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
kayexalate	kayexalate	NN	I-NP	B-protein
x	x	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
,	,	,	O	O
UTI	UTI	NN	B-NP	B-DNA
,	,	,	O	O
protein	protein	NN	B-NP	O
C	C	NN	I-NP	O
def	def	NN	I-NP	O
s/p	s/p	NN	I-NP	O
DVT	DVT	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
morbid	morbid	JJ	B-NP	O
obesity	obesity	NN	I-NP	O
Meds	Med	NNS	I-NP	O
:	:	:	O	O
see	see	VB	B-VP	O
med	me	VBN	B-NP	O
section	section	NN	I-NP	O
Allergies	Allergy	NNS	I-NP	O
:	:	:	O	O
NKDA	NKDA	NNP	B-NP	O
Exam	Exam	NNP	I-NP	O
:	:	:	O	O
T98	T98	NNP	B-NP	O
H76	H76	NNP	I-NP	O
BP156/82	BP156/82	NNP	I-NP	O
General	General	NNP	I-NP	O
:	:	:	O	O
obese	obese	JJ	B-NP	O
woman	woman	NN	I-NP	O
,	,	,	O	O
NAD	NAD	NNP	B-NP	O
Cor	Cor	NNP	I-NP	O
:	:	:	O	O
S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
S4	S4	NN	B-NP	O
Abd	Abd	NN	I-NP	O
:	:	:	O	O
large	large	JJ	B-NP	O
Labs	Lab	NNS	I-NP	O
:	:	:	O	O
BUN/Cr	BUN/Cr	NN	B-NP	B-protein
-	-	HYPH	O	O
85/2	85/2	CD	B-NP	O
.2	.2	CD	I-NP	O
WBC	WBC	NNP	I-NP	O
19	19	CD	I-NP	O
K5	K5	NN	I-NP	O
.7	.7	CD	B-NP	O
Hct	Hct	NN	I-NP	O
31.8	31.8	CD	B-NP	O
-LRB-	-LRB-	SYM	I-NP	O
baseline	baseline	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
U/A	U/A	NN	I-NP	O
+	+	SYM	B-NP	O
****************************************	****************************************	SYM	B-VP	O
62	62	CD	B-NP	O
y/o	y/o	NN	I-NP	O
woman	woman	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
MRSA	MRSA	NN	I-NP	O
UTI	UTI	NN	I-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
UTI	UTI	NN	I-NP	O
:	:	:	O	O
initially	initially	RB	B-NP	O
rx	rx	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
bactrim	bactrim	NN	I-NP	O
but	but	CC	O	O
we	we	PRP	B-NP	O
d/cd	d/cd	VBD	B-VP	O
this	this	DT	B-NP	O
2/2	2/2	CD	I-NP	O
elev	elev	NN	I-NP	O
Cr	Cr	NN	I-NP	O
,	,	,	O	O
electrolye	electrolye	NN	B-NP	O
abnormalities	abnormality	NNS	I-NP	O
and	and	CC	O	O
switched	switch	VBN	B-VP	O
to	to	TO	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
on	on	IN	B-PP	O
which	which	WDT	B-NP	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
inserted	insert	VBN	B-VP	O
so	so	IN	B-SBAR	O
she	she	PRP	B-NP	O
cou	cou	PRP	B-NP	O
ld	ld	VBD	B-VP	O
complete	complete	JJ	B-ADJP	O
a	a	DT	B-NP	O
14	14	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
complicated	complicate	VBN	I-NP	O
MRSA	MRSA	NN	I-NP	O
+	+	SYM	B-NP	O
UTI	UTI	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
cxs	cx	NNS	I-NP	O
were	be	VBD	B-VP	O
drawn	draw	VBN	I-VP	O
to	to	TO	B-VP	O
r/o	r/o	VB	I-VP	O
bacteremia	bacteremia	NN	B-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
low	low	JJ	I-NP	O
grade	grade	NN	I-NP	O
temps	temp	NNS	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
neg	neg	NN	B-NP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
gave	give	VBD	B-VP	O
her	her	PRP	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
pyridium	pyridium	NN	B-NP	O
for	for	IN	B-PP	O
sx	sx	NN	B-NP	O
relief	relief	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
hang	hang	VB	I-VP	O
her	her	PRP$	B-NP	O
own	own	JJ	I-NP	O
vancomycin	vancomycin	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
-RRB-	-RRB-	:	O	O
Renal	Renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
:	:	:	O	O
baseline	baseline	NN	B-NP	O
50/2	50/2	CD	B-NP	O
.5	.5	CD	I-NP	O
;	;	:	O	O
checked	check	VBN	B-NP	O
urine	urine	NN	I-NP	O
lytes	lyte	NNS	I-NP	O
which	which	WDT	B-NP	O
suggested	suggest	VBD	B-VP	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
dry	dry	JJ	B-ADJP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
initiated	initiate	VBD	B-VP	O
gentle	gentle	JJ	B-NP	O
hydration	hydration	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
underlying	underlying	JJ	I-NP	O
CHF	CHF	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
and	and	CC	I-NP	O
teh	teh	NN	I-NP	O
blood	blood	NN	I-NP	O
we	we	PRP	B-NP	O
gave	give	VBD	B-VP	O
her	her	PRP	B-NP	O
have	have	VB	B-VP	O
helped	help	VBD	I-VP	O
her	her	PRP$	B-NP	O
Cr	Cr	NN	I-NP	O
return	return	NN	I-NP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
US	US	NNP	I-NP	O
normal	normal	JJ	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
hematuria	hematuria	NN	B-NP	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
h	h	VB	I-VP	O
ave	ave	RB	I-VP	O
been	be	VBN	I-VP	O
2/2	2/2	CD	B-NP	O
the	the	DT	B-NP	O
foley	foley	NN	I-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
she	she	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
mild	mild	JJ	I-NP	O
urinary	urinary	JJ	I-NP	O
retention	retention	NN	I-NP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
are	be	VBP	B-VP	O
suggesting	suggest	VBG	I-VP	O
an	an	DT	B-NP	O
outpt	outpt	JJ	I-NP	O
cystoscopy	cystoscopy	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
We	We	PRP	B-NP	O
were	be	VBD	B-VP	O
holding	hold	VBG	I-VP	O
her	her	PRP$	B-NP	O
ACE	ACE	NN	I-NP	O
+	+	SYM	B-VP	O
diuretic	diuretic	JJ	B-ADJP	O
until	until	IN	B-PP	O
her	her	PRP$	B-NP	O
last	last	JJ	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
volume	volume	NN	I-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
Cr	Cr	NN	B-NP	O
elev	elev	NN	I-NP	O
.	.	.	O	O

we	we	PRP	B-NP	O
monitored	monitor	VBD	B-VP	O
her	her	PRP$	B-NP	O
BP	BP	NN	I-NP	O
off	off	IN	B-PP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
meds	med	NNS	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
;	;	:	O	O
We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
her	her	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

We	We	PRP	B-NP	O
restarted	restart	VBD	B-VP	O
her	her	PRP$	B-NP	O
ACE	ACE	NN	I-NP	O
and	and	CC	O	O
diuretic	diuretic	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
but	but	CC	O	O
d/cd	d/cd	VBD	B-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
2mg	2mg	NN	B-NP	O
qd	qd	NN	I-NP	O
of	of	IN	B-PP	O
bumex	bumex	NN	B-NP	O
instead	instead	RB	B-PP	O
of	of	IN	I-PP	O
2	2	CD	B-NP	O
bid	bid	NN	I-NP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
came	come	VBD	B-VP	O
in	in	RP	B-PRT	O
on	on	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
DM	DM	NN	I-NP	O
:	:	:	O	O
we	we	PRP	B-NP	O
continued	continue	VBD	B-VP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
insulin	insulin	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
FS	FS	NN	I-NP	B-protein
were	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Dispo	Dispo	NNP	I-NP	O
:	:	:	O	O
w	w	NN	B-NP	O
/	/	SYM	I-NP	O
PICC	PICC	NN	I-NP	O
line	line	NN	I-NP	O
and	and	CC	I-NP	O
abx	abx	NN	I-NP	O
for	for	IN	B-PP	O
10	10	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Schupbach	Schupbach	NNP	I-NP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
take	take	VB	B-VP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
and	and	CC	O	O
listed	list	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
discharge	discharge	NN	I-NP	O
papers	paper	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
your	your	PRP$	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
be	be	VB	I-VP	O
sure	sure	JJ	B-ADJP	O
to	to	TO	B-VP	O
contact	contact	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Lapinski	Lapinski	NNP	I-NP	O
to	to	TO	B-VP	O
set	set	VB	I-VP	O
up	up	RP	B-PRT	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
being	be	VBG	B-VP	O
to	to	TO	I-VP	O
re-experience	re-experience	VB	I-VP	O
severe	severe	JJ	B-NP	O
burning	burning	NN	I-NP	O
again	again	RB	B-ADVP	O
with	with	IN	B-PP	O
urination	urination	NN	B-NP	O
or	or	CC	O	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
begin	begin	VBP	B-VP	O
to	to	TO	I-VP	O
get	get	VB	I-VP	O
high	high	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-INTJ	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
or	or	CC	O	O
return	return	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Satisfactory	Satisfactory	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
PECHON	PECHON	NNP	B-NP	O
,	,	,	O	O
ANTWAN	ANTWAN	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HQ703	HQ703	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8/12/04	8/12/04	CD	I-NP	O
@	@	NN	I-NP	O
09	09	CD	I-NP	O
:	:	:	O	O
37	37	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

